Pular para o conteúdo

Interações medicamentosas

Efavirenz + Lomitapide

Gravidade: Contraindicada

Efavirenz and Lomitapide: contraindicated interaction.

Última atualização

Para profissionais de saúde — apenas referência. Esta página é um resumo breve, não é aconselhamento médico nem substitui a bula oficial ou o julgamento clínico. Verifique sempre antes de prescrever ou dispensar.

O conteúdo clínico desta página está disponível apenas em inglês.

Resumo

Lomitapide is a sensitive CYP3A4 substrate and exposure can rise markedly with interacting drugs, increasing hepatotoxicity and gastrointestinal adverse effects. Efavirenz is a mixed CYP3A4 modulator and the net effect is uncertain, but the label restricts such combinations.

O que esta interação significa em palavras simples

Efavirenz and Lomitapide are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two.

Efavirenz belongs to Anti Virals; Lomitapide belongs to Cardiovascular.

Nível de evidência: Low

Por que acontece

Efavirenz modulation of CYP3A4 alters lomitapide metabolism, with potential for increased exposure.

O que fazer

Avoid the combination and choose a different lipid-lowering strategy or antiretroviral. If lomitapide is essential, monitor liver enzymes closely.

O que perguntar ao farmacêutico

  • Is there an alternative to one of these two medicines for me?
  • If both are essential, who is monitoring me and how often?
  • Which symptoms mean I should stop and seek help straight away?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Para assinantes do Pro+

Desbloqueie a página completa

Crie uma conta e comece um teste do Pro+ para desbloquear a orientação completa de conduta para Efavirenz e Lomitapide, as notas adicionais, os detalhes da evidência e o verificador de interações para uma prescrição completa.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Experimente o Pro+ grátis por 7 dias na web. Sem cartão.

Perguntas frequentes

Can I take Efavirenz with Lomitapide?

MediHelp rates the interaction as contraindicated. Efavirenz and Lomitapide are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two. Lomitapide is a sensitive CYP3A4 substrate and exposure can rise markedly with interacting drugs, increasing hepatotoxicity and gastrointestinal adverse effects. Efavirenz is a mixed CYP3A4 modulator and the net effect is uncertain, but the label restricts such combinations.

How serious is the interaction between Efavirenz and Lomitapide?

MediHelp rates it contraindicated, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination and choose a different lipid-lowering strategy or antiretroviral. If lomitapide is essential, monitor liver enzymes closely.

What other medicines interact with Efavirenz?

MediHelp also lists interactions of Efavirenz with, for example, Cobimetinib, Dienogest / estradiol valerate, Dihydroergotamine intranasal. The full list is on the Efavirenz page.

Monografias completas, posologia e verificador de interações no app MediHelp

Abra a referência completa, verifique interações entre vários medicamentos e use as ferramentas de posologia no app MediHelp.

Explorar de A a Z · Interações medicamentosas

Baixar o app Entrar